

Human Microbiome Sequencing Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
The Human Microbiome Sequencing market is witnessing robust growth, driven by increasing research funding and rising awareness of microbiome impacts on health. The market size is projected to reach approximately $1.5 billion by 2027, reflecting a compound annual growth rate of over 20%, fueled by advancements in sequencing technologies and applications.
Request Sample Report
◍ Baseclear B.V.
◍ Beijing Genomics Institute (BGI) Genomics Co., Ltd
◍ Charles River Laboratories International Inc.
◍ Clinical Microbiomics A/S
◍ Eurofins Scientific SE
◍ GENEWIZ, Inc.
◍ Illumina, Inc.
◍ Novogene Corporation
◍ OraSure Technologies, Inc.
◍ Oxford Nanopore Technologies, Inc.
◍ Pacific Biosciences of California, Inc.
◍ QIAGEN N.V.
◍ Second Genome, Inc.
◍ Thermo Fisher Scientific Inc.
◍ Viome, Inc.
◍ CosmosID
◍ Leucine Rich Bio Pvt. Ltd.
◍ Microba
The Human Microbiome Sequencing Market features companies like Illumina, QIAGEN, and Thermo Fisher, among others, providing advanced sequencing technologies and services. These companies drive market growth through innovative products, partnerships, and research to expand microbiome applications across healthcare, agriculture, and environmental sectors, enhancing understanding of microbial interactions and health.
Sales Revenue Figures (examples):
- Illumina, Inc.: Approximately $3.3 billion
- Thermo Fisher Scientific Inc.: Approximately $38 billion
- Eurofins Scientific SE: Approximately $5.5 billion
- BGI Genomics Co., Ltd: Approximately $1 billion
Request Sample Report
◍ Genome Analysis
◍ Metabolome Analysis
◍ Transcriptome Analysis
◍ Other Omics Analysis
◍ Next-Generation Sequencing
◍ Traditional Sequencing Technologies
◍ Other
Request Sample Report
Request Sample Report
$ X Billion USD